ALKS

Alkermes Plc (ALKS) Investor Questions

Review Alkermes Plc (ALKS) faq with company data, supporting context and links to related investor research.

Research record updated: . Individual measures may refer to different reporting periods.

Company
Alkermes Plc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Overall BTI score
72
Annual revenue
$1.48B
Annual net income
$241.66M
Annual free cash flow
$480.33M

Alkermes Plc (ALKS) Investor Questions research

Alkermes Plc trades under the ticker ALKS. The company is classified in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry.

Investors commonly review ALKS through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.